HENNEMAN JOHN B III - Insider Non-Derivative Transactions at Anika Therapeutics, Inc. (ANIK) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Jul 9, 2024, HENNEMAN JOHN B III's relationship to Anika Therapeutics, Inc. (ANIK) is Director, and currently has 35,707 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other ANIK insiders.
Data Source: SEC.
HENNEMAN JOHN B III - Insider Non-Derivative Transactions of ANIK Common Stock
HENNEMAN JOHN B III - Insider Non-Derivative Transactions at ANIK
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Jul 10, 2024 | Acquisition -- (Common Stock) | 5771 | 0 | 35707 |
| Jun 15, 2023 | Acquisition -- (Common Stock) | 6500 | 0 | 29936 |